Raymond James Financial »

Janux Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-06-30 $7.6k 331 23.10

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
Paradigm Biocapital Advisors
Adage Capital Partners GP
Vanguard Group
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Logos Global Management
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Readystate Asset Management

View all funds holding Janux Therapeutics